Skip to main content

Peer Review reports

From: Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations

Original Submission
25 Mar 2020 Submitted Original manuscript
21 Jun 2020 Reviewed Reviewer Report - katsuhiko naoki
23 Jul 2020 Author responded Author comments - Yuichiro Takeda
Resubmission - Version 2
23 Jul 2020 Submitted Manuscript version 2
3 Aug 2020 Author responded Author comments - Yuichiro Takeda
Resubmission - Version 3
3 Aug 2020 Submitted Manuscript version 3
12 Aug 2020 Reviewed Reviewer Report
18 Aug 2020 Reviewed Reviewer Report - katsuhiko naoki
12 Sep 2020 Author responded Author comments - Yuichiro Takeda
Resubmission - Version 4
12 Sep 2020 Submitted Manuscript version 4
Publishing
16 Sep 2020 Editorially accepted
2 Oct 2020 Article published 10.1186/s12885-020-07424-w

You can find further information about peer review here.

Back to article page